Russell Gilandra K, Gupta Ramesh C, Vadhanam Manicka V
Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, United States.
Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, United States; James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, United States.
Mutat Res. 2015 Apr;774:25-32. doi: 10.1016/j.mrfmmm.2015.02.003. Epub 2015 Feb 25.
Dibenzo[a,l]pyrene (DBP) has been found to be the most potent carcinogen of the polycyclic aromatic hydrocarbons (PAHs). Primary sources for DBP in the environment are combustion of wood and coal burning, gasoline and diesel exhaust, and tires. Given the likelihood of environmental exposure to DBP and strong experimental evidence of its potency, it is likely to contribute to lung cancer development. Intervention with compounds of natural origin ("phytochemicals") is considered an effective means to prevent cancer development and favorably modulate the underlying mechanisms, including DNA adduct formation. In this study, several agents have been identified that inhibit environmental carcinogen-induced DNA adduct formation using a cell-free microsomal system. Of the ten agents tested, resveratrol (648 ± 26 adducts/10(9) nucleotides), oltipraz (1007 ± 348 adducts/10(9) nucleotides), delphinidin (1252 ± 142 adducts/10(9) nucleotides), tanshinone I (1981 ± 213 adducts/10(9) nucleotides), tanshinone IIA (2606 ± 478 adducts/10(9) nucleotides) and diindoylmethane (3643 ± 469 adducts/10(9) nucleotides) were the most effective compared to vehicle treatment (14,062 ± 1097 adducts/10(9) nucleotides). DBP is metabolized by phase I metabolizing enzymes CYP1A1, CYP1A2, and CYP1B1. DBP-induced DNA adducts can be inhibited by several mechanisms. We found that all the test agents inhibited DNA adducts by inhibiting one or more of these enzymes. Oltipraz inhibited DNA adducts entirely by inhibiting the CYP450s, while resveratrol and delphinidin inhibited DNA adducts by also interacting directly with the carcinogenic metabolite, anti-dibenzo(a,l)pyrene-11,12-dihydrodiol-13,14-epoxide.
二苯并[a,l]芘(DBP)被发现是多环芳烃(PAHs)中最具致癌性的物质。环境中DBP的主要来源是木材燃烧、煤炭燃烧、汽油和柴油尾气以及轮胎。鉴于环境中接触DBP的可能性以及其致癌性的有力实验证据,它很可能会导致肺癌的发生。用天然来源的化合物(“植物化学物质”)进行干预被认为是预防癌症发生并有利地调节潜在机制(包括DNA加合物形成)的有效手段。在本研究中,使用无细胞微粒体系统鉴定了几种抑制环境致癌物诱导的DNA加合物形成的试剂。在所测试的十种试剂中,与载体处理(14,062±1097个加合物/10⁹个核苷酸)相比,白藜芦醇(648±26个加合物/10⁹个核苷酸)、奥替普拉(1007±348个加合物/10⁹个核苷酸)、飞燕草素(1252±142个加合物/10⁹个核苷酸)、丹参酮I(1981±213个加合物/10⁹个核苷酸)、丹参酮IIA(2606±478个加合物/10⁹个核苷酸)和二吲哚甲烷(3643±469个加合物/10⁹个核苷酸)是最有效的。DBP由I相代谢酶CYP1A1、CYP1A2和CYP1B1代谢。DBP诱导的DNA加合物可以通过多种机制被抑制。我们发现所有测试试剂都通过抑制这些酶中的一种或多种来抑制DNA加合物。奥替普拉完全通过抑制细胞色素P450来抑制DNA加合物,而白藜芦醇和飞燕草素还通过与致癌代谢物反式二苯并(a,l)芘-11,12-二氢二醇-13,14-环氧化物直接相互作用来抑制DNA加合物。